Literature DB >> 11054427

Characterization of the biosynthesis of human immunodeficiency virus type 1 Env from infected T-cells and the effects of glucose trimming of Env on virion infectivity.

M Dettenhofer1, X F Yu.   

Abstract

HIV (human immunodeficiency virus)-1 Env is displayed on the surface of infected cells and subsequently incorporated into virions, which is necessary for the initiation of a viral infection by recognition of the CD4 and the chemokine receptors (such as CCR5 or CXCR4) on the surface of new target cells. As a type 1 integral membrane glycoprotein, Env is cotranslationally translocated into the endoplasmic reticulum. In this report, we characterized the synthesis of Env, which did not occur at a constant rate but by translational/translocational pausing that has not previously been shown with a viral encoded glycoprotein. Overall translation was not impeded by the presence of the reducing agent dithiothreitol in vivo, although this did influence the cleavage of the precursor gp160 into its mature form, gp120. Env interacts transiently with resident components of the endoplasmic reticulum such as calnexin, which had maximal association at a 10-min post-translation. Addition of the glucosidase inhibitor, castanospermine, failed to significantly influence the association of Env with calnexin, consistent with the notion that calnexin recognizes components other than alpha-terminal glucose. Moreover, castanospermine treatment failed to affect the infectivity of virions. Taken together, this report demonstrates the existence of translational/translocational pausing for a viral glycoprotein and suggests that trimming of glucose from HIV-1 Env is not essential for the initiation of virus infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054427     DOI: 10.1074/jbc.M008933200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Circuit assemblages derived from net dinucleotide values provide a succinct identity for the HIV-1 genome and each of its genes.

Authors:  Dorothy M Lang
Journal:  Virus Genes       Date:  2007-11-07       Impact factor: 2.332

2.  Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomerase.

Authors:  Marie-Jeanne Papandréou; Rym Barbouche; Régis Guieu; Santiago Rivera; Jacques Fantini; Michel Khrestchatisky; Ian M Jones; Emmanuel Fenouillet
Journal:  J Biol Chem       Date:  2010-03-04       Impact factor: 5.157

3.  Membrane topology analysis of HIV-1 envelope glycoprotein gp41.

Authors:  Shujun Liu; Naoyuki Kondo; Yufei Long; Dan Xiao; Aikichi Iwamoto; Zene Matsuda
Journal:  Retrovirology       Date:  2010-11-30       Impact factor: 4.602

4.  Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif.

Authors:  Serena Bernacchi; Gaëlle Mercenne; Clémence Tournaire; Roland Marquet; Jean-Christophe Paillart
Journal:  Nucleic Acids Res       Date:  2010-11-13       Impact factor: 16.971

5.  The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function.

Authors:  Mark J Hollier; Nigel J Dimmock
Journal:  Virology       Date:  2005-07-05       Impact factor: 3.616

6.  HIV-1 protein Nef inhibits activity of ATP-binding cassette transporter A1 by targeting endoplasmic reticulum chaperone calnexin.

Authors:  Lucas Jennelle; Ruth Hunegnaw; Larisa Dubrovsky; Tatiana Pushkarsky; Michael L Fitzgerald; Dmitri Sviridov; Anastas Popratiloff; Beda Brichacek; Michael Bukrinsky
Journal:  J Biol Chem       Date:  2014-08-28       Impact factor: 5.157

7.  Demonstration of a novel HIV-1 restriction phenotype from a human T cell line.

Authors:  Yanxing Han; Xiaojun Wang; Ying Dang; Yong-Hui Zheng
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

8.  Co-expression of foreign proteins tethered to HIV-1 envelope glycoprotein on the cell surface by introducing an intervening second membrane-spanning domain.

Authors:  Hongyun Wang; Xiao Li; Shuhei Nakane; Shujun Liu; Hirohito Ishikawa; Aikichi Iwamoto; Zene Matsuda
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.